DISCOVER therapeutic antibodies: kinetics of antibody-drug conjugates measured directly on cells
Webinar Overview
In this episode of the Bruker Biosensors DISCOVER MOLECULAR INTERACTIONS webinar series we will discuss antibody-drug conjugates and how to characterize their target engagement directly on living cells using single-cell Interaction Cytometry.
Key Learning Objectives
This webinar is part of the webinar series DISCOVER MOLECULAR INTERACTIONS by Bruker Biosensors. Marc-André Kasper from Tubulis GmbH is presenting how they develop next generation antibody-drug conjugates with the help of novel proprietary technologies.
As most antibodies target transmembrane proteins, interactions of these molecules with their targets should be characterized directly on cells to maintain the unique native environment of the cellular membrane. In this episode, you will learn how Tubulis used single-cell Interaction Cytometry (scIC) to measure kinetics directly on cells to support their ADC development.
Speaker
Marc-André Kasper, Ph.D.
Vice president for Chemistry and Early Discovery, Tubulis GmbH, Munich, Germany